09:54 AM EST - Bradmer Pharmaceuticals Inc. : reported third-quarter net loss of $722,000, or $0.06 U.S. per share, compared to net loss of $2.63 million U.S. or $0.19 U.S. per share last year. Research expenses declined to $43,000 U.S. from $1.9 million U.S. in the same quarter last year. Bradmer Pharmaceuticals Inc.
shares T.BMR are trading even at $0.14.
